[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone

C32H33BrFN3O3 — CID 141102825

IUPAC[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone
SMILESO=C(c1ccc(Br)c(COc2ccc(-c3nc4ccccc4n3C3CCCCC3)c(F)c2)c1)N1CCC(O)CC1
InChIInChI=1S/C32H33BrFN3O3/c33-27-13-10-21(32(39)36-16-14-24(38)15-17-36)18-22(27)20-40-25-11-12-26(28(34)19-25)31-35-29-8-4-5-9-30(29)37(31)23-6-2-1-3-7-23/h4-5,8-13,18-19,23-24,38H,1-3,6-7,14-17,20H2
InChIKeyFXBXNQVIODCCIL-UHFFFAOYSA-N
MW606.54 g/mol
LogP7.29
Rot. Bonds6

About [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone

[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone (PubChem CID 141102825) has the molecular formula C32H33BrFN3O3 and a molecular weight of 606.54 g/mol. Its IUPAC name is [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone.

Molecular Properties

Compound Name[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone
PubChem CID141102825
Molecular FormulaC32H33BrFN3O3
Molecular Weight606.54 g/mol
Exact Mass605.17
IUPAC Name[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone
SMILESO=C(c1ccc(Br)c(COc2ccc(-c3nc4ccccc4n3C3CCCCC3)c(F)c2)c1)N1CCC(O)CC1
InChIInChI=1S/C32H33BrFN3O3/c33-27-13-10-21(32(39)36-16-14-24(38)15-17-36)18-22(27)20-40-25-11-12-26(28(34)19-25)31-35-29-8-4-5-9-30(29)37(31)23-6-2-1-3-7-23/h4-5,8-13,18-19,23-24,38H,1-3,6-7,14-17,20H2
InChIKeyFXBXNQVIODCCIL-UHFFFAOYSA-N
XLogP7.29
TPSA67.59 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500606.54
LogP ≤ 57.29
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone?
The IUPAC name of [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone (CID 141102825) is [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone.
What is the SMILES notation for [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone?
The canonical SMILES for [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone is O=C(c1ccc(Br)c(COc2ccc(-c3nc4ccccc4n3C3CCCCC3)c(F)c2)c1)N1CCC(O)CC1.
What is the InChIKey of [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone?
The InChIKey is FXBXNQVIODCCIL-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H33BrFN3O3/c33-27-13-10-21(32(39)36-16-14-24(38)15-17-36)18-22(27)20-40-25-11-12-26(28(34)19-25)31-35-29-8-4-5-9-30(29)37(31)23-6-2-1-3-7-23/h4-5,8-13,18-19,23-24,38H,1-3,6-7,14-17,20H2.
What are the key properties of [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone?
[4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone has a molecular weight of 606.54 g/mol, XLogP of 7.29, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [4-bromo-3-[[4-(1-cyclohexylbenzimidazol-2-yl)-3-fluorophenoxy]methyl]phenyl]-(4-hydroxypiperidin-1-yl)methanone is sourced from PubChem (CID 141102825), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).